Price dualization for NIP cervical cancer vaccines

Cervical cancer vaccines for the National Immunization Program(NIP) which will be conducted from this June are expected to be decided at dualized prices.

According to the pharmaceutical industry, it was told the Korea Centers for Disease Control and Prevention(KCDC) will finalize the decision on whether to have dual prices or a single price for tetravalent Gardasil and bivalent Cervarix within...